QN - search results | myHealthbox

niquitin 14 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 78 mg/15 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme

United Kingdom - English - myHealthbox

niquitin 21 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 114 mg/22 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme.

United Kingdom - English - myHealthbox

niquitin 7 mg transdermal patches

omega pharma ltd - nicotine - transdermal patch. - 36 mg/ 7 cm2 - anti-smoking agents - niquitin patches relieve and/or prevent craving and nicotine withdrawal symptoms associated with tobacco dependence. they are indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. niquitin patches are indicated in pregnant and lactating women making a quit attempt. if possible, when stopping smoking, niquitin patches should be used in conjunction with a behavioural support programme

United States - English - NLM (National Library of Medicine)

d-67 (ammonium carbonate, hydrogen cyanide, camphor- natural, activated charcoal, crotalus durissus terrificus venom, tobacco le

dna labs, inc. - ammonium carbonate (unii: nj5vt0fklj) (carbonate ion - unii:7ujq5ope7d), hydrogen cyanide (unii: 2wtb3v159f) (hydrogen cyanide - unii:2wtb3v159f), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), activated charcoal (unii: 2p3vwu3h10) (activated charcoal - unii:2p3vwu3h10), crotalus durissus terrificus venom (unii: 2xf6i0446g) (crotalus durissus terrificus venom - unii:2xf6i0446g), tobacco leaf (unii: 6yr2608rsu) (tobacco leaf - unii:6yr2608rsu), veratrum album root (unii: qn - supports healthy circulation.